ANS-6,7,8 Flashcards
Monoamines contain one ___ group connected to an aromatic ring by ___ carbon chain
amino, 2
examples of monoamines include
serotonin, dopamine, norepinephrine, epinephrine, and (histamine)
Catecholamines are monoamines with a ___ group
catechol
Examples of catecholamines
dopamine, norepinephrine, and epinephrine
BioSynthesis of Catecholamines:
1) tyrosine, 2) ____, 3) Dopamine, 4) ___, 5) epinephrine
L-Dopa, Norepinephrine
What step (enzyme) of catecholamine biosynthesis is rate limiting?
tyrosine hydroxylase
What is this?
L-Tyrosine
What inhibits tyrosine hydroxylase?
it’s tyrosine with a methyl on it
Metyrosine (Demser)
What inhibits L-Aromatic Amino Acid Decarboxylase?
Carbidopa
Norepinephrine Neurotransmission: Step 1 - ___ is transported into the ___ ending or varicosity by a ___ dependent carrier
Tyrosine, noradrenergic, sodium
Norepinephrine Neurotransmission: Step 2 - tyrosine is converted to ___ by tyrosine ___ which is converted to ___ by L-dopa ___
L-dopa, hydroxylase, dopamine, decarboxylase
Norepinephrine Neurotransmission: Step 3 - ___ is transported into the vesicle by ___
dopamine, vesicular monoamine transporter (VMAT)
*VMAT also transfers NE and other amines into vesicles as well
Norepinephrine Neurotransmission: Step 4 - Dopamine is converted to ___ in the vesicles by ___
NE, dopamine-B-hydroxylase
Norepinephrine Neurotransmission: Step 5 - release of neurotransmitter occurs when an ___ opens voltage-sensitive ___ channels and increases intracellular calcium. Fusion of vesicles with the surface membranes results in expulsion of NE
action potential, calcium
Norepinephrine Neurotransmission: Step 6 - NE binds to ___ receptors on the postsynaptic cell
adrenergic
Norepinephrine Neurotransmission: Step 7 - NE binds to ___ receptors present on the ___ terminal
regulatory, presynaptic
Norepinephrine Neurotransmission: Step 8 - NE diffuses out of the cleft or is re-uptaken into the cytoplasm of the terminal by the ___ where it is metabolized by ___ or transported by ___ back into vesicles
NE transporter (NET), Monoamine oxidase (MAO), VMAT
Norepinephrine Neurotransmission: Step 9 - NE can also diffuse away from the synaptic cleft into other cells where it can be degraded by ___
catechol-O-methyltransferase (COMT)
What is this?
Dopamine
What receptors does epinephrine work on?
B1, B2, a1, a2
basically all of them
What receptors does norepinephrine work on?
a1, a2, B1
Direct acting adrenergic receptor agonists: Norepinephrine
* Potent ___ and ___ receptor agonist
* substrate for ___ and ___ (metabolized quickly)
* ___ administeration
* Sodium bisulfite used in preparations to prevent ___
* used as a ___
- a1, B1
- MAO, COMT
- parenteral
- oxidation
- pressor (vasoconstriction)
Direct acting adrenergic receptor agonists: Epinephrine
* Potent ___, ___, and ___ receptor agonist
* Substrate for ___ and ___
* ____ administration
* Sodium bisulfite used in preparations to prevent ___
* available as many salts: hydrochloride, nitrate, and bitartrate
* used for ___ in combination with local anesthetics
- a, B1, B2
- MAO, COMT
- parenteral
- oxidation
- anaphylaxis
Epinephrine:
Lower [ ] effects at ___ and ___ predominately.
Higher [ ] effects at ___ predominantly
Lower: B1 and B2
Higher: a1
Clinical use of epinephrine:
treatment of ____ or ____ ; adjunct with local ____
acute anaphylaxis, cardiac arrest, anesthetics
Problems with epinephrine: not orally active due to ___ and ___ breakdown in the liver (___ metabolism). Can produce unwanted effects through broad activation of ___ receptors
MAO and COMT, first pass, adrenergic
Main action of Norepinephrine:
* activates ___ and ___ receptors. Little affinity for ____
* ___ agonist (vasoconstriction leading to a rise in BP)
* ___ agonist (cardiac stimulation by increase in force and conduction)
- activates a and B1 receptors. Little affinity for B2
- a1
- B1
Main action of Epinephrine:
* activates __ and __ receptors
* ___ agonist (Vasocontriction leading to a rise in BP)
* ___ agonist (Cardiac stimulation by increasing in force, rate, and conduction)
* ___ agonist (Vasodilation leasing to fall in BP and bronchodilation)
- a and B
- a1
- B1
- B2
Main action of Dopamine:
Lower doses -
* ___ agonist (Vasodilation in renal, messenteric, and coronary arteries increasing blood flow)
* ___ agonist (cardiac stimulation by increasing in force, rate and conduction)
Higher doses -
* ___ agonist (Vasoconstriction leading to a rise in blood pressure)
- D1
- B1
- a1
Directly-acting receptor agonists: D1 agonist Dopamine (Intropin) Action-
* Renal D1-receptor agonist, renal vessel ___
* Direct and indirect ___ and ____ agonist (high dose)
* cardiac stimulation and systemic ____ outside the kidney
- Dilation
- B1 and a1
- vasoconstrictor
Clinical use for Dopamine (Intropin)
shock, acute congestive heart failure
T or F: Dopamine must be given via IV
True
What is this?
Fenoldopam
Selective D1 agonist used for severe hypertension in hospitalized patients
Direct acting adrenergic receptor agonists: mixed b1, a1 receptor agonists - Dobutamine (Dobutrex)
* (+)-enantiomer: potent __ receptor agonist
* (-)-enantiomer: potent __ receptor agonist, potency for B receptors reduced (10x)
* racemic exerts a much stronger ___ than chronotropic effect
- B1
- a1
- inotropic
T or F: Dobutamine (Dobutrex) is metabolized by MAO and not sensitive to COMT
False; Dobutamine (Dobutrex) is metabolized by COMT and not sensitive to MAO
Direct acting adrenergic receptor agonists: mixed b1, a1 receptor agonists - Dobutamine (Dobutrex)
* ___ half life (2 __)
* Administered via ___
* Used for acute ___, shock, and “stress tests”
- short, minutes
- IV
- heart failure
Adrenergic Receptor Subtypes-a1(Gq): Agonist uses
- nasal decongestion
- mydriasis without cycloplegia
- pressor
- vasoconstrictor in regional anesthesia (keep drug localized)
- vascular failure in shock and supraventricular tachycardia
Adrenergic Receptor Subtypes-a1(Gq): Antagonist uses
- hypertension
- benign prostatic hyperplasia
- pheochromocytoma
pheochromocytoma - benign tumor that develops in an adrenal gland.
Direct acting adrenergic receptor agonists:
a1 receptors - Examples
- Phenylephrine (Neosynephrine)
- Methoxamine (Vasoxyl)
- Oxymetazoline (Visine)
What is this?
Phenylephrine (Neosynephrine)
direct a1 agonist
Direct a 1 Agonist: Phenylephrine
Administration can be ___, ___, or ___
parenteral, oral, or local
T or F: Phenylephrine is a substrated for MAO
True